Preclinical models have shown decreased RelB expression with doxycycline treatment in ovarian cancer cells in addition to significantly decreased spheroid formation, possibly due to increased c-myc-cyclins D1 and E [1, 56]. This evidence concerns the gene RELB and ovarian carcinoma.